文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

膀胱癌患者根治性膀胱切除术前预测需要扩大淋巴结清扫术的需求。

Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.

机构信息

Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland.

Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland.

出版信息

Eur Urol Focus. 2021 Sep;7(5):1067-1074. doi: 10.1016/j.euf.2020.09.009. Epub 2020 Oct 2.


DOI:10.1016/j.euf.2020.09.009
PMID:33020030
Abstract

BACKGROUND: A prospective randomized trial (LEA AUO AB 25/02) found no survival benefit in extended compared with limited pelvic lymph node dissection (PLND) templates in bladder cancer (BCa) patients treated with radical cystectomy (RC). However, the rate of lymph node invasion (LNI) in the standard and extended templates was lower than estimated. OBJECTIVE: To assess the accuracy of preoperative clinical and pathological parameters to predict LNI and to develop a model to preoperatively select candidates for the extended PLND templates. DESIGN, SETTING, AND PARTICIPANTS: A total of 903 BCa patients treated at a single institution were retrospectively identified. The primary outcome was to identify preoperatively the risk of LNI to tailor the type of PLND. The extended PLND templates consisted in the removal of pelvic lymph nodes together with the common iliac, presacral, para-aortocaval, interaortocaval, and paracaval sites up to the inferior mesenteric artery. INTERVENTION: A total of 903 BCa patients were treated with RC and bilateral extended PLND templates. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Several models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots and decision curve analyses. A nomogram predicting LNI in the extended pattern was developed and validated internally. RESULTS AND LIMITATIONS: Overall, 55 patients (6.1%) had LNI in the extended PLND templates at RC. The median number of nodes removed was 19 (interquartile range: 13-26). A model including age, clinical T stage, clinical node stage, lymphovascular invasion, and presence of carcinoma in situ at the last transurethral resection before RC was developed. The AUC of this model is 73%. Using a cutoff of 3%, 108 extended PLNDs (12%) would be spared and only two LNIs (3%) would be missed. The main limitations of our model are the retrospective nature of the data, lack of external validation, and low rate of LNI. CONCLUSIONS: This is the first proposed model to predict LNI in the extended PLND templates. This model might help urologists identify which patients might benefit from an extended PLND at the time of RC, reserving a standard PLND for all the others. PATIENT SUMMARY: We developed the first nomogram to predict lymph node invasion (LNI) in the extended pelvic lymph node dissection templates in bladder cancer patients treated with radical cystectomy. The adoption of our model to identify candidates for the extended pelvic lymph node dissection templates could avoid up to 12% of these procedures at the cost of missing only 3% of patients with LNI.

摘要

背景:一项前瞻性随机试验(LEA AUO AB 25/02)发现,在接受根治性膀胱切除术(RC)治疗的膀胱癌(BCa)患者中,与局限性盆腔淋巴结清扫术(PLND)模板相比,扩展 PLND 模板并没有生存获益。然而,标准和扩展模板中的淋巴结侵犯(LNI)率低于预期。

目的:评估术前临床和病理参数预测 LNI 的准确性,并建立一种模型,以便在术前选择接受扩展 PLND 模板的候选人。

设计、设置和参与者:共回顾性确定了 903 例在单一机构接受治疗的 BCa 患者。主要结局是术前识别 LNI 的风险,以定制 PLND 的类型。扩展 PLND 模板包括切除盆腔淋巴结,以及共同髂动脉、骶前、腹主动脉旁、腹主动脉内和腔静脉旁部位,直至肠系膜下动脉。

干预措施:共 903 例 BCa 患者接受 RC 和双侧扩展 PLND 模板治疗。

结局测量和统计分析:使用受试者工作特征曲线下面积(AUC)、校准图和决策曲线分析评估了几种预测 LNI 的模型。开发并内部验证了一种预测扩展模式 LNI 的列线图。

结果和局限性:总体而言,在 RC 中,55 例(6.1%)患者在扩展 PLND 模板中出现 LNI。切除的淋巴结中位数为 19 个(四分位距:13-26)。建立了一个包含年龄、临床 T 分期、临床淋巴结分期、淋巴血管侵犯和 RC 前最后一次经尿道切除术时原位癌存在的模型。该模型的 AUC 为 73%。使用 3%的截断值,可避免 108 例扩展 PLND(12%),仅漏诊 2 例 LNI(3%)。我们模型的主要局限性是数据的回顾性、缺乏外部验证以及 LNI 发生率低。

结论:这是第一个用于预测 RC 中扩展 PLND 模板中 LNI 的模型。该模型可能有助于泌尿科医生在 RC 时识别哪些患者可能受益于扩展 PLND,从而为所有其他患者保留标准 PLND。

患者总结:我们开发了第一个列线图来预测接受根治性膀胱切除术的膀胱癌患者的扩展盆腔淋巴结清扫模板中的淋巴结侵犯(LNI)。采用我们的模型来识别接受扩展盆腔淋巴结清扫模板的候选人,可以避免多达 12%的此类手术,而漏诊的 LNI 患者仅占 3%。

相似文献

[1]
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.

Eur Urol Focus. 2021-9

[2]
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Eur Urol. 2018-10-17

[3]
Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.

Cochrane Database Syst Rev. 2019-5-14

[4]
Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.

BJU Int. 2013-1-16

[5]
Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.

Eur Urol. 2017-4-12

[6]
Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer.

Urol Oncol. 2018-6

[7]
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.

Eur Urol Oncol. 2023-12

[8]
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.

Clin Genitourin Cancer. 2022-4

[9]
Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.

Nat Rev Urol. 2018-11

[10]
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.

Eur Urol. 2018-10-15

引用本文的文献

[1]
Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.

Bladder Cancer. 2025-8-21

[2]
Perioperative outcomes using template mapping after radical cystectomy and extended lymph node dissection.

BMC Urol. 2025-4-16

[3]
Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma.

BMC Cancer. 2024-6-13

[4]
Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.

Urol Oncol. 2024-1

[5]
Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.

Cancers (Basel). 2023-1-18

[6]
Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+).

Cancers (Basel). 2022-10-27

[7]
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.

BJU Int. 2022-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索